Robert Mandić
Impact in
- Virology top 5%
- HIV Research and Treatment
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
-
- RNA Interference and Gene Delivery 7
- Oncology 17
- Peptidase Inhibition and Analysis 5
- HER2/EGFR in Cancer Research 3
- Co-authors
- Jochen A. Werner (32 shared papers)Susanne Wiegand (9 shared papers)B. Matija Peterlin (4 shared papers)Michael Bette (22 shared papers)Yong‐Hui Zheng (3 shared papers)Thomas Linnemann (3 shared papers)Peter Barth (3 shared papers)Behfar Eivazi (8 shared papers)
- Journals
- Pharmaceutics (3 papers)Oral Oncology (3 papers)Acta Oto-Laryngologica (3 papers)Anticancer Research (2 papers)Gene (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Robert Mandić
69 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Virology 112
- Otorhinolaryngology 72
- Oncology 349
- Cancer Research 175
- Surgery 284
Countries citing papers authored by Robert Mandić
This map shows the geographic impact of Robert Mandić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mandić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mandić more than expected).
Fields of papers citing papers by Robert Mandić
This network shows the impact of papers produced by Robert Mandić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mandić. The network helps show where Robert Mandić may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Mandić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 117 | |
| 2 | 2002 | 94 | |
| 3 | 2002 | 88 | |
| 4 | 2022 | 75 | |
| 5 | 2002 | 70 | |
| 6 | 2009 | 62 | |
| 7 | 2007 | 50 | |
| 8 | 2009 | 48 | |
| 9 | 2005 | 45 | |
| 10 | 2005 | 42 | |
| 11 | 2008 | 41 | |
| 12 | 2001 | 36 | |
| 13 | 2006 | 35 | |
| 14 | 2009 | 35 | |
| 15 | 2016 | 35 | |
| 16 | 2014 | 32 | |
| 17 | Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits. | 2003 | 31 |
| 18 | 2020 | 30 | |
| 19 | 2017 | 24 | |
| 20 | 2016 | 22 |
About Robert Mandić
Robert Mandić is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 71 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Vascular Malformations and Hemangiomas (5 papers), Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Cellular transport and secretion (3 papers), HER2/EGFR in Cancer Research (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Virology (112 citations), Otorhinolaryngology (72 citations), Oncology (349 citations), Cancer Research (175 citations) and Surgery (284 citations). Robert Mandić has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jochen A. Werner, Susanne Wiegand, B. Matija Peterlin, Michael Bette, Yong‐Hui Zheng, Thomas Linnemann, Peter Barth, Behfar Eivazi, Afshin Teymoortash and Matthias Geyer. Their work appears in journals such as Pharmaceutics, Oral Oncology, Acta Oto-Laryngologica, Anticancer Research and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.